Zobrazeno 1 - 10 of 90 pro vyhledávání: '"J. Kolitz"'
2
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin’s lymphoma
Autor: William D. Boswell, Bharat N. Nathwani, D. McDonald, L.A. Buchanan, Alexandra M. Levine, J. Kolitz, L. Roberts, J. Letzer, G.R. Justice, Byron M. Espina, Anil Tulpule, A. Traynor, A. Myers, J. Bernstein, M. U. Rarick
Publikováno v: Annals of Oncology. 12:457-462
Summary Purpose To assess the efficacy and toxicity of liposomal daunorubicin administered as a two-hour intravenous infusion to patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL) Patients and methods Eligible patients had relapsed o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb220058a2e35e94fb4c29aa693f54c
https://doi.org/10.1023/a:1011181016401
Zobrazit plný text záznamu
3
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
Autor: Janice Gabrilove, Ellin Berman, Subhash C. Gulati, S McKenzie, J Santorsa, G. Heller, Michael Andreeff, J. Kolitz, Timothy Gee, Sanford Kempin
Publikováno v: Blood. 77:1666-1674
4′-Demethoxydaunorubicin (idarubicin [IDR]) is a new anthracycline that differs from its parent compound by the deletion of a methoxy group at position 4 of the chromophore ring. This minor structural modification results in a more lipophilic compo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e379c1718f53e1223d62be37f4df4db
https://doi.org/10.1182/blood.v77.8.1666.1666
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses
Autor: J, Pinilla-Ibarz, K, Cathcart, T, Korontsvit, S, Soignet, M, Bocchia, J, Caggiano, L, Lai, J, Jimenez, J, Kolitz, D A, Scheinberg
Publikováno v: Blood. 95(5)
Chronic myelogenous leukemia (CML) presents a unique opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also the oncogenic protein required for neoplasia. CML is characterized by the t(9;22)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d7dccd9e0ca6035144e25b766dcae12a
https://pubmed.ncbi.nlm.nih.gov/10688838
Zobrazit plný text záznamu
7
Malignant hemangioendothelioma presenting as multifocal intraskeletal lesions during pregnancy. A case report
Autor: J A, Ilasi, T F, Smilari, J, Kolitz, I, Zanzi, S I, Hajdu
Publikováno v: The Journal of reproductive medicine. 44(1)
Malignant hemangioendothelioma is a neoplasm of vascular origin characterized by irregular vascular channels lined with atypical endothelial cells.A gravida at 32 weeks' gestation presented with diffuse back and lower leg pain and was diagnosed with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::03cb3c18132ca798f37ca98a658735e0
https://pubmed.ncbi.nlm.nih.gov/9987740
Zobrazit plný text záznamu
8
Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma
Autor: P R, Koduru, K, Raju, V, Vadmal, G, Menezes, S, Shah, M, Susin, J, Kolitz, J D, Broome
Publikováno v: Blood. 90(10)
In the biology of a cell, the central role of p53 in controlling functions such as G1/S transition (check point) and DNA damage repair, and as a trigger of apoptosis, is well established. Somatic mutations or other changes in P53 have been reported i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7b5ff6bcdd77f98ead64a38c8925c599
https://pubmed.ncbi.nlm.nih.gov/9354678
Zobrazit plný text záznamu
9
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022
Autor: J O, Moore, R K, Dodge, P C, Amrein, J, Kolitz, E J, Lee, B, Powell, S, Godfrey, F, Robert, C A, Schiffer
Publikováno v: Blood. 89(3)
This study evaluated the effect of filgrastim (granulocyte colony-stimulating factor [G-CSF]) on the duration of granulocytopenia and thrombocytopenia after intensive consolidation therapy with diaziquone (AZO) and mitroxantrone for patients less tha
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9fb8f9099e1ad577cda94dcacd13426e
https://pubmed.ncbi.nlm.nih.gov/9028308
Zobrazit plný text záznamu
10
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia
Autor: D, Serrano, J, Monteiro, S L, Allen, J, Kolitz, P, Schulman, S M, Lichtman, A, Buchbinder, V P, Vinciguerra, N, Chiorazzi, P K, Gregersen
Publikováno v: Journal of immunology (Baltimore, Md. : 1950). 158(3)
The role of T cells in chronic lymphocytic leukemia (CLL) has not been extensively investigated, since the most prominent cellular abnormality in CLL involves the clonal expansion of B cells. In this study we have undertaken a comprehensive analysis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ae42a49575fb30ff216abd5e78ce849a
https://pubmed.ncbi.nlm.nih.gov/9013995
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje